Evaluation of a thyroid nodule.
暂无分享,去创建一个
[1] L. Hurtado-López,et al. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT or MIBI scan? , 2007, Surgery.
[2] P. Hasselgren,et al. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. , 2005, Surgery.
[3] S. Mandel,et al. Sonographic imaging of thyroid nodules and cervical lymph nodes. , 2008, Endocrinology and metabolism clinics of North America.
[4] J. Serpell,et al. Management of the solitary thyroid nodule. , 2008, The oncologist.
[5] F. Marincola,et al. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. , 1995, Immunology today.
[6] M. Surks,et al. The changing role of scintigraphy in the evaluation of thyroid nodules. , 2000, Seminars in nuclear medicine.
[7] Gerard M Doherty,et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.
[8] W. Strodel,et al. Is thyroid frozen section too much for too little? , 2002, American journal of surgery.
[9] P. Ladenson,et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. , 2005, The Journal of clinical endocrinology and metabolism.
[10] A. Pinchera,et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. , 2004, The Journal of clinical endocrinology and metabolism.
[11] D. Sarti,et al. Thyroid Incidentalomas: Prevalence by Palpation and Ultrasonography , 1994 .
[12] D. Heron,et al. Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma. , 2010, Archives of otolaryngology--head & neck surgery.
[13] J. Freeman,et al. Risk factors for well-differentiated thyroid carcinoma in patients with thyroid nodular disease , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[14] Z. Baloch,et al. Is fine-needle aspiration (FNA) of multiple thyroid nodules justified? , 2006, Endocrine pathology.
[15] A. Mooradian,et al. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. , 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[16] J. Norton,et al. Large cystic/solid thyroid nodules: a potential false-negative fine-needle aspiration. , 1995, Surgery.
[17] P. Parikh,et al. Covalent linking of proteins and cytokines to suture: Enhancing the immune response of head and neck cancer patients , 2003, The Laryngoscope.
[18] P. Larsen,et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. , 2006, The Journal of clinical endocrinology and metabolism.
[19] B. Hanna,et al. A preliminary study of simple voice assessment in a routine clinical setting to predict vocal cord paralysis after thyroid or parathyroid surgery , 2008, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[20] B. Cho,et al. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto‐pathology diagnosis, especially in BRAFV600E mutation‐prevalent area , 2006, Clinical endocrinology.
[21] Miren Osorio,et al. Molecular Markers in Thyroid Fine-needle Aspiration Biopsy: A Prospective Study , 2009, Applied immunohistochemistry & molecular morphology : AIMM.
[22] D. Castro,et al. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck. , 2001, Archives of Otolaryngology - Head and Neck Surgery.
[23] Y. Nikiforov,et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. , 2004, The Journal of clinical endocrinology and metabolism.
[24] V. Lowe,et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET–CT , 2007, Nuclear medicine communications.
[25] M. Nikiforova,et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. , 2009, The Journal of clinical endocrinology and metabolism.
[26] P. Singer,et al. Evaluation and management of the solitary thyroid nodule. , 1996, Otolaryngologic clinics of North America.
[27] Yuri E Nikiforov,et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.
[28] Anna Crescenzi,et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. , 2002, The Journal of clinical endocrinology and metabolism.
[29] G. Troncone,et al. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings , 2007, Clinical endocrinology.
[30] W. Oyen,et al. 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] L. Hegedüs,et al. Clinical practice. The thyroid nodule. , 2004, The New England journal of medicine.
[32] T. Turkington,et al. Clinical applications of PET in oncology. , 2004, Radiology.
[33] L. Hegedüs,et al. The Thyroid Nodule , 2004 .
[34] B Nygaard,et al. Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. , 1998, Thyroid : official journal of the American Thyroid Association.
[35] J. Serpell,et al. Does frozen section have a role in the intraoperative management of thyroid nodules? , 2002, ANZ journal of surgery.
[36] M. Sidawy,et al. Fine‐needle aspiration of thyroid nodules , 1997, Cancer.
[37] Matthew C. Miller,et al. Intraoperative pathologic examination: cost effectiveness and clinical value in patients with cytologic diagnosis of cellular follicular thyroid lesion. , 2007, Thyroid : official journal of the American Thyroid Association.
[38] A. Pinchera,et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. , 2008, The Journal of clinical endocrinology and metabolism.
[39] L. Woolner,et al. Gross and microscopic findings in clinically normal thyroid glands. , 1955, The Journal of clinical endocrinology and metabolism.
[40] S. Carty,et al. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. , 2007, Surgery.
[41] Christopher Wong,et al. Thyroid Nodules: Rational Management , 2000, World Journal of Surgery.
[42] Juan Rosai,et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference , 2008, Diagnostic cytopathology.
[43] Ho Kyu Lee,et al. Ultrasonography‐guided fine‐needle aspiration of thyroid incidentaloma: correlation with pathological findings , 2004, Clinical endocrinology.
[44] T. Giordano,et al. Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary Carcinomas , 2006, The American journal of surgical pathology.
[45] A. Pontecorvi,et al. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. , 1998, Thyroid : official journal of the American Thyroid Association.